APP and early-onset autosomal dominant Alzheimer disease: In addition, studies of NRBF2 in Alzheimer’s disease revealed that NRBF2 plays an important role in regulating the degradation of APP C-terminal fragments by modulating autophagy and could be a potential therapeutic target for Alzheimer’s disease [11, 13].